Balancing best practices with patient affordability and literacy. Here’s how one doctor adapts treatment plans for real-world ...

Cognitive performance was not different among four classes of glucose-lowering medications for type 2 diabetes, data from the ...

Discover upcoming breakthroughs in Type 1 Diabetes & B-cell disorder treatments, market growth to $24B by 2031, and key ...

In certain types of cancer, PPARγ can contribute to tumor growth or metabolic changes. The drug, pioglitazone, is a so-called agonist that binds to a PPARy receptor and activates it. Thereby it ...

Indian drug cos are increasing their presence in the insulin market. They are competing with multinational corporations.

The lawsuits come amid several recent studies showing a link between vision complications and people taking drugs ...

Pharma giant Eli Lilly’s weight loss drug Mounjaro is priced between Rs. 10,000- ₹15,000 in India making it inaccessible to a ...

Discover how popular GLP-1 weight loss medications like Ozempic may trigger eating disorder relapse in vulnerable users and ...

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...

A recent study found that the main compound in cinnamon, cinnamaldehyde, which gives the spice its unique smell and taste, ...

As weight loss medications like Ozempic continue to gain popular, experts and patients are noticing varying effects of the drugs for people with eating disorders.